The use of radiomic analysis of magnetic resonance imaging in predicting distant metastases of rectal carcinoma following surgical resection: A systematic review and meta-analysis.
MRI
carcinoma
distant metastases
radiomics
rectal
Journal
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
revised:
03
08
2021
received:
28
04
2021
accepted:
12
09
2021
pubmed:
19
9
2021
medline:
29
1
2022
entrez:
18
9
2021
Statut:
ppublish
Résumé
Estimating prognosis in rectal carcinoma (RC) is challenging, with distant recurrence (DR) occurring in up to 30% of cases. Radiomics is a novel field using diagnostic imaging to investigate the tumour heterogeneity of cancers and may have the potential to predict DR. The aim of the study was to perform a systematic review of the current literature evaluating the use of radiomics in predicting DR in patients with resected RC. A systematic review was performed as per PRISMA guidelines to identify studies reporting radiomic analysis of magnetic resonance imaging (MRI) to predict DR in patients diagnosed with RC. Sensitivity and specificity of radiomic analyses were included for meta-analysis. A total of seven studies including 1497 patients (998 males) were included, seven, five and one of whom reported radiomics, respectively. The overall pooled rate of DR from all included studies was 17.1% (256/1497), with 15.6% (236/1497), 1.3% (19/1497) and 0.2% (3/1497) of patients having hepatic, pulmonary and peritoneal metastases. Meta-analysis demonstrated that radiomics correctly predicted DR with pooled sensitivities and specificities of MRI 0.76 (95% CI: 0.73, 0.78) and 0.85 (95% CI: 0.83, 0.88), respectively. This systematic review suggests the benefit of radiomic analysis of preoperative MRI in identifying patients with resected RC at an increased risk of DR. Our findings warrant validation in larger prospective studies as modalities to predict DR is a significant unmet need in RC. Radiomics may allow for tailored therapeutic strategies for high-risk groups.
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3065-3072Informations de copyright
© 2021 The Association of Coloproctology of Great Britain and Ireland.
Références
Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 2005;16(3):481-8. https://doi.org/10.1093/annonc/mdi098
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492
Wang J, Li S, Liu Y, Zhang C, Li H, Lai B. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: a population-based analysis. Cancer Med. 2020;9(1):361-73. https://doi.org/10.1002/cam4.2673
Feeney G, Sehgal R, Sheehan M, et al. Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol. 2019;25(33):4850-69. https://doi.org/10.3748/wjg.v25.i33.4850
Hogan NM, Dwyer RM, Joyce MR, Kerin MJ. Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications. Int J Cancer. 2012;131(1):1-7. https://doi.org/10.1002/ijc.27458
Georgiou PA, Tekkis PP, Brown G. Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options. Cancer Imaging. 2011;11:S103-11. https://doi.org/10.1102/1470-7330.2011.9025
van Timmeren JE, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B. Radiomics in medical imaging-"how-to" guide and critical reflection. Insights Imaging. 2020;11(1):91. https://doi.org/10.1186/s13244-020-00887-2
Fiz F, Viganò L, Gennaro N, et al. Radiomics of liver metastases: a systematic review. Cancers (Basel). 2020;12(10):2881. https://doi.org/10.3390/cancers12102881
Staal FCR, van der Reijd DJ, Taghavi M, Lambregts DMJ, Beets-Tan RGH, Maas M. Radiomics for the prediction of treatment outcome and survival in patients with colorectal cancer: a systematic review. Clin Colorectal Cancer. 2020;20(1):52-71. https://doi.org/10.1016/j.clcc.2020.11.001
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. https://doi.org/10.1136/bmj.b2535
Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https://doi.org/10.1136/bmj.j4008
Macaskill P, Gatsonis C, Deeks J, Harbord R, Takwoingi Y. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 09 0. London: The Cochrane Collaboration, 2010;83.
Labianca R, Nordlinger B, Beretta GD, et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;6:vi64-72. https://doi.org/10.1093/annonc/mdt354
Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93-9. https://doi.org/10.3322/caac.21388
Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749-62. https://doi.org/10.1038/nrclinonc.2017.141
Chiloiro G, Rodriguez-Carnero P, Lenkowicz J, et al. Delta radiomics can predict distant metastasis in locally advanced rectal cancer: the challenge to personalize the cure. Front Oncol. 2020;10:595012. https://doi.org/10.3389/fonc.2020.595012
Hu T, Wang S, Huang L, et al. A clinical-radiomics nomogram for the preoperative prediction of lung metastasis in colorectal cancer patients with indeterminate pulmonary nodules. Eur Radiol. 2019;29(1):439-49. https://doi.org/10.1007/s00330-018-5539-3
Liang M, Cai Z, Zhang H, et al. Machine learning-based analysis of rectal cancer MRI Radiomics for prediction of metachronous liver metastasis. Acad Radiol. 2019;26(11):1495-504.
Liu H, Zhang C, Wang L, et al. MRI radiomics analysis for predicting preoperative synchronous distant metastasis in patients with rectal cancer. Eur Radiol. 2019;29(8):4418-26. https://doi.org/10.1007/s00330-018-5802-7
Liu M, Ma X, Shen F, Xia Y, Jia Y, Lu J. MRI-based radiomics nomogram to predict synchronous liver metastasis in primary rectal cancer patients. Cancer Med. 2020;9(14):5155-63. https://doi.org/10.1002/cam4.3185
Liu Z, Meng X, Zhang H, et al. Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer. Nat Commun. 2020;11(1):4308. https://doi.org/10.1038/s41467-020-18162-9
Nardone V, Reginelli A, Scala F, et al. Magnetic-Resonance-Imaging Texture Analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation. Gastroenterol Res Pract. 2019;2019:8505798. https://doi.org/10.1155/2019/8505798
Qin H, Wu YQ, Lin P, et al. Ultrasound image-based radiomics. J Ultrasound Med. 2021;40(6):1229-44. https://doi.org/10.1002/jum.15506
Shu Z, Fang S, Ding Z, et al. MRI-based Radiomics nomogram to detect primary rectal cancer with synchronous liver metastases. Sci Rep. 2019;9(1):3374. https://doi.org/10.1038/s41598-019-39651-y
Taghavi M, Trebeschi S, Simões R, et al. Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases. Abdom Radiol (NY). 2021;46(1):249-56. https://doi.org/10.1007/s00261-020-02624-1
Nougaret S, Tibermacine H, Tardieu M, Radiomics SE. Radiomics: an introductory guide to what it may foretell. Curr Oncol Rep. 2019;21(8):70. https://doi.org/10.1007/s11912-019-0815-1
Granzier RWY, van Nijnatten TJA, Woodruff HC, Smidt ML, Lobbes MBI. Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: a systematic review. Eur J Radiol. 2019;121:108736. https://doi.org/10.1016/j.ejrad.2019.108736
Sollini M, Cozzi L, Chiti A, Kirienko M. Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: where do we stand? Eur J Radiol. 2018;99:1-8. https://doi.org/10.1016/j.ejrad.2017.12.004
Rizzo S, Manganaro L, Dolciami M, Gasparri ML, Papadia A, Del Grande F. Computed tomography based radiomics as a predictor of survival in ovarian cancer patients: a systematic review. Cancers. 2021;13(3):573. https://doi.org/10.3390/cancers13030573
Ursprung S, Beer L, Bruining A, et al. Radiomics of computed tomography and magnetic resonance imaging in renal cell carcinoma-a systematic review and meta-analysis. Eur Radiol. 2020;30(6):3558-66. https://doi.org/10.1007/s00330-020-06666-3.
Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv263. https://doi.org/10.1093/annonc/mdy161
Zaborowski A, Stakelum A, Winter DC. Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer. Br J Surg. 2019;106(8):979-87. https://doi.org/10.1002/bjs.11171
Pita-Fernández S, Alhayek-Aí M, González-Martín C, López-Calviño B, Seoane-Pillado T, Pértega-Díaz S. Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis. Ann Oncol. 2015;26(4):644-56. https://doi.org/10.1093/annonc/mdu543
Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem. 2001;47(4):624-30.
Korphaisarn K, Kopetz S. BRAF-directed therapy in metastatic colorectal cancer. Cancer J. 2016;22(3):175-8. https://doi.org/10.1097/ppo.0000000000000189
Bao Y. Radiomics Assess of Bevacizumab Plus Chemo in Colorectal Cancer Liver Metastases (ROBOT) Trial. Peking University People's Hospital. https://clinicaltrials.gov/ct2/show/NCT04213222?cond=colorectal+radiomics&draw=2&rank=2. Accessed 29 Sep 2021.